Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia

Khaled M. Musallam, Susanna Barella, Raffaella Origa, Giovanni Battista Ferrero, Roberto Lisi, Annamaria Pasanisi, Filomena Longo, Barbara Gianesin, Gian Luca Forni

Blood (2024) 143 (10): 930–932.

https://doi.org/10.1182/blood.2023022460

Published: 2024

Journal Articles

Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYOND Study

Khaled M Musallam, Ali T Taher, Antonis Kattamis, Maria Domenica Cappellini, Jennifer Lord-Bessen, Mrudula Glassberg, Christopher Pelligra, Shien Guo, Loyse Felber Medlin, Luciana Moro Bueno, Kevin H.M. Kuo

Blood (2023) 142 (Supplement 1): 2474.

https://doi.org/10.1182/blood-2023-173366

Published: 2023

Journal Articles

Luspatercept for the Treatment of Anemia in Non-Transfusion-Dependent β-Thalassemia: Final Safety and Efficacy Data from the BEYOND Trial

Ali T Taher, Vip Viprakasit, Antonis Kattamis, Silverio Perrotta, Paolo Ricchi, John B. Porter, Thomas D Coates, Gian Luca Forni, Khaled M. Musallam, Oriana Esposito, Ana Carolina Giuseppi, Wen-Ling Kuo, Marta Reverte, Richard Wei, Luciana Moro Bueno, Maria Domenica Cappellini

Blood (2023) 142 (Supplement 1): 3847.

https://doi.org/10.1182/blood-2023-174097

Published: 2023

Journal Articles

How I treat non-transfusion-dependent β-thalassemia

Antoine N. Saliba, Khaled M. Musallam, Ali T. Taher

Blood (2023) 142 (11): 949–960.

https://doi.org/10.1182/blood.2023020683

Published: 2023

Includes: Supplemental data

Journal Articles

Erythroid Response in Patients with Non-Transfusion-Dependent β-Thalassemia Treated with Luspatercept: Long-Term Data from the BEYOND Trial

Ali T. Taher, Vip Viprakasit, Maria Domenica Domenica Cappellini, Antonio Piga, John B. Porter, Thomas D. Coates, Khaled M. Musallam, Gian Luca Forni, Jeevan K. Shetty, Marija Bosilkovska Weisskopf, Richard Wei, Wen-Ling Kuo, Antonis Kattamis

Blood (2022) 140 (Supplement 1): 8210–8212.

https://doi.org/10.1182/blood-2022-157512

Published: 2022

Journal Articles

Characterizing the Clinical, Health-Related Quality of Life and Economic Burden of Alpha-Thalassemia: A Systematic Literature Review and Evidence Gaps Assessment

Khaled M. Musallam, Louise Lombard, Keely Gilroy, Lydia Vinals, Candice Tam, Maria Rizzo

Blood (2022) 140 (Supplement 1): 2491–2493.

https://doi.org/10.1182/blood-2022-167125

Published: 2022

Journal Articles

A Closer Look at Changes in Hemoglobin Levels in Patients with Non-Transfusion Dependent β-Thalassemia Treated with Luspatercept: Post Hoc Analysis of the Phase 2 BEYOND Trial

Khaled M. Musallam, Ali T. Taher, John B. Porter, Antonis Kattamis, Mrudula B. Glassberg, Luciana Bueno, Jeevan K. Shetty, Frederik Lersch, Barbara Rosettani, Maria Domenica Domenica Cappellini

Blood (2022) 140 (Supplement 1): 5358–5359.

https://doi.org/10.1182/blood-2022-157113

Published: 2022

Journal Articles

Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization

Valeria Maria Pinto, Khaled M. Musallam, Giorgio Derchi, Giovanna Graziadei, Marianna Giuditta, Raffaella Origa, Susanna Barella, Gavino Casu, Annamaria Pasanisi, Filomena Longo, Maddalena Casale, Roberta Miceli, Pierluigi Merella, Immacolata Tartaglione, Antonio Piga, Maria Domenica Cappellini, Barbara Gianesin, Gian Luca Forni, on behalf of the Webthal project

Blood (2022) 139 (13): 2080–2083.

https://doi.org/10.1182/blood.2021014862

Published: 2022

Journal Articles

A Phase 2a Study Evaluating the Safety and Pharmacokinetics (PK) of Luspatercept in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT)

Vip Viprakasit, Thomas D. Coates, Khaled M. Musallam, Julie Vienne Buerki, Meera Patturajan, Natalia Holot, Yesim Aydinok

Blood (2021) 138 (Supplement 1): 4161.

https://doi.org/10.1182/blood-2021-145698

Published: 2021

Journal Articles

Greater Red Blood Cell Transfusion Burden Is Associated with More Healthcare Resource Utilization in Patients with Beta-Thalassemia

Chao-Hsiun Tang, Wesley Furnback, Bruce C.M. Wang, Jackson Tang, Vicky Wei-Hsuen Huang, Derek Tang, PhD BSPharm, Meng-Yao Lu, Khaled M. Musallam

Blood (2019) 134 (Supplement_1): 5790.

https://doi.org/10.1182/blood-2019-122747

Published: 2019

Journal Articles

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia

Khaled M. Musallam, Ali T. Taher, Maria Domenica Cappellini, Vijay G. Sankaran

Blood (2013) 121 (12): 2199–2212.

https://doi.org/10.1182/blood-2012-10-408021

Published: 2013

Journal Articles

Estimation of the Prevalence of Pulmonary Artery Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization

Giorgio Derchi, Renzo Galanello, MD, Patrizio Bina, Maria D Cappellini, Antonio Piga, MD, Maria-Eliana Lai, Antonella Quarta, Gavino Casu, Silverio Perrotta, Khaled M Musallam, Gian Luca Forni, MD

Blood (2012) 120 (21): 3262.

https://doi.org/10.1182/blood.V120.21.3262.3262

Published: 2012

Journal Articles

Elevated Hematocrit Concentration and the Risk of Mortality and Vascular Events in Patients Undergoing Major Surgery.

Khaled M Musallam, John B Porter, MD, Assaad Soweid, Jamal J Hoballah, Pierre M Sfeir, Mohamed Khalife, Salah Zeineldine, Hani M Tamim, Toby Richards, Luca Andrea Lotta, Flora Peyvandi, Faek R Jamali

Blood (2012) 120 (21): 2088.

https://doi.org/10.1182/blood.V120.21.2088.2088

Published: 2012

Journal Articles

Prevalence and Risk Factors of Left Ventricular Noncompaction in Patients with β-Thalassemia.

Antonio Piga, MD, Filomena Longo, Khaled M Musallam, Andrea Veltri, Lia Davicino, Rodolfo Bonamini

Blood (2012) 120 (21): 2127.

https://doi.org/10.1182/blood.V120.21.2127.2127

Published: 2012

Journal Articles

Serum Ferritin Levels and Morbidity in β-Thalassemia Intermedia: A 10-Year Cohort Study

Khaled M Musallam, MD, PhD, Maria D Cappellini, Shahina Daar, Mehran Karimi, Amal El-Beshlawy, Ali T Taher, MD

Blood (2012) 120 (21): 1021.

https://doi.org/10.1182/blood.V120.21.1021.1021

Published: 2012

Journal Articles

Evaluation of the 5 Mg/g Liver Iron Concentration Threshold and Its Association with Vascular and Endocrine/Bone Morbidity in β-Thalassemia Intermedia

Khaled M Musallam, Maria D Cappellini, Ali T Taher, MD

Blood (2012) 120 (21): 1024.

https://doi.org/10.1182/blood.V120.21.1024.1024

Published: 2012

Journal Articles

Assessment and Management of Iron Overload in β-Thalassemia Major Patients in Italy: A Real-Life Experience From the Webthal® Project

Antonio Piga, MD, Filomena Longo, Khaled M Musallam, Maria Domenica Cappellini, MD, Gian Luca Forni, MD, Giovanni Quarta, Francesco Chiavilli, Francesca Valeria Commendatore, Sergio Mulas, Vincenzo Caruso, Renzo Galanello, MD

Blood (2012) 120 (21): 1030.

https://doi.org/10.1182/blood.V120.21.1030.1030

Published: 2012

Journal Articles

Iron Chelation Therapy and Mobilization of Hematopoietic Peripheral Progenitors in Patients with β-Thalassemia Major

Gian Luca Forni, MD, Marina Podestà, Marco Musso, Giovanna Piaggio, Khaled M Musallam, Manuela Balocco, Sarah Pozzi, Francesco Frassoni

Blood (2012) 120 (21): 5178.

https://doi.org/10.1182/blood.V120.21.5178.5178

Published: 2012

Journal Articles

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

Luca A. Lotta, Haifeng M. Wu, Ian J. Mackie, Marina Noris, Agnes Veyradier, Marie A. Scully, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, Richard A. Gibbs, April Horne, Shangbin Yang, Isabella Garagiola, Khaled M. Musallam, Flora Peyvandi

Blood (2012) 120 (2): 440–448.

https://doi.org/10.1182/blood-2012-01-403113

Published: 2012

Includes: Supplemental data

Journal Articles

A new chelator in the house

Ali T. Taher, Khaled M. Musallam

Blood (2012) 119 (14): 3191–3192.

https://doi.org/10.1182/blood-2012-02-406744

Published: 2012

NARROW

Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia

Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYOND Study

Luspatercept for the Treatment of Anemia in Non-Transfusion-Dependent β-Thalassemia: Final Safety and Efficacy Data from the BEYOND Trial

How I treat non-transfusion-dependent β-thalassemia

Erythroid Response in Patients with Non-Transfusion-Dependent β-Thalassemia Treated with Luspatercept: Long-Term Data from the BEYOND Trial

Characterizing the Clinical, Health-Related Quality of Life and Economic Burden of Alpha-Thalassemia: A Systematic Literature Review and Evidence Gaps Assessment

A Closer Look at Changes in Hemoglobin Levels in Patients with Non-Transfusion Dependent β-Thalassemia Treated with Luspatercept: Post Hoc Analysis of the Phase 2 BEYOND Trial

Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization

A Phase 2a Study Evaluating the Safety and Pharmacokinetics (PK) of Luspatercept in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT)

Greater Red Blood Cell Transfusion Burden Is Associated with More Healthcare Resource Utilization in Patients with Beta-Thalassemia

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia

Estimation of the Prevalence of Pulmonary Artery Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization

Elevated Hematocrit Concentration and the Risk of Mortality and Vascular Events in Patients Undergoing Major Surgery.

Prevalence and Risk Factors of Left Ventricular Noncompaction in Patients with β-Thalassemia.

Serum Ferritin Levels and Morbidity in β-Thalassemia Intermedia: A 10-Year Cohort Study

Evaluation of the 5 Mg/g Liver Iron Concentration Threshold and Its Association with Vascular and Endocrine/Bone Morbidity in β-Thalassemia Intermedia

Assessment and Management of Iron Overload in β-Thalassemia Major Patients in Italy: A Real-Life Experience From the Webthal® Project

Iron Chelation Therapy and Mobilization of Hematopoietic Peripheral Progenitors in Patients with β-Thalassemia Major

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

A new chelator in the house

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only